Laboratorio Reig Jofre S.A. | Mid-cap | Healthcare
€2.75
-0.36%
| Laboratorio Reig Stock Comparison:
Laboratorio Reig vs LaboratoriosLaboratorio Reig vs Almirall S.ALaboratorio Reig vs Faes Farma S.ALaboratorio Reig vs Labiana Health S.ALaboratorio Reig vs Grifols, S.ALaboratorio Reig vs IBEX 35 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Dec 2024

Income Metrics

Revenue 166.2M
Gross Profit 97.1M 58.43%
Operating Income 6.9M 4.15%
Net Income 4.9M 2.97%
EPS (Diluted) €0.06

Balance Sheet Metrics

Total Assets 344.9M
Total Liabilities 130.9M
Shareholders Equity 214.0M
Debt to Equity 0.61

Cash Flow Metrics

Revenue & Profitability Trend

Laboratorio Reig Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i338.9M316.1M271.2M236.2M230.1M
Cost of Goods Sold i143.2M137.1M113.8M91.3M89.7M
Gross Profit i195.7M179.0M157.3M145.0M140.4M
Gross Margin % i57.7%56.6%58.0%61.4%61.0%
Operating Expenses
Research & Development i6.0M5.4M4.5M4.9M3.8M
Selling, General & Administrative i26.5M22.7M20.0M18.2M16.8M
Other Operating Expenses i37.2M39.3M32.3M30.1M26.8M
Total Operating Expenses i69.7M67.4M56.8M53.2M47.4M
Operating Income i15.1M12.4M9.2M9.4M9.9M
Operating Margin % i4.4%3.9%3.4%4.0%4.3%
Non-Operating Items
Interest Income i287.0K63.0K101.0K50.0K32.0K
Interest Expense i1.0M745.0K687.0K679.0K680.0K
Other Non-Operating Income-----
Pre-tax Income i11.8M10.5M8.8M5.8M6.4M
Income Tax i1.4M1.1M658.0K713.0K760.0K
Effective Tax Rate % i11.5%10.5%7.5%12.3%11.8%
Net Income i10.5M9.4M8.1M5.1M5.7M
Net Margin % i3.1%3.0%3.0%2.2%2.5%
Key Metrics
EBITDA i37.7M36.2M31.7M27.0M26.7M
EPS (Basic) i€0.13€0.12€0.10€0.07€0.07
EPS (Diluted) i€0.13€0.12€0.10€0.07€0.07
Basic Shares Outstanding i8006772878804046788818547785405476985445
Diluted Shares Outstanding i8006772878804046788818547785405476985445

Income Statement Trend

Laboratorio Reig Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i10.5M5.5M6.5M5.1M11.6M
Short-term Investments i5.6M830.0K298.0K973.0K102.0K
Accounts Receivable i57.2M56.9M52.2M47.2M45.4M
Inventory i63.7M61.7M48.1M47.6M40.4M
Other Current Assets1.6M2.0M2.1M4.4M463.0K
Total Current Assets i149.7M132.6M112.3M108.8M100.7M
Non-Current Assets
Property, Plant & Equipment i8.8M8.8M8.3M7.8M5.8M
Goodwill i108.9M119.0M128.8M137.4M142.8M
Intangible Assets i55.3M63.1M70.9M77.7M82.8M
Long-term Investments-----
Other Non-Current Assets----4.0K
Total Non-Current Assets i195.2M198.0M208.9M216.1M216.4M
Total Assets i344.9M330.5M321.2M325.0M317.2M
Liabilities
Current Liabilities
Accounts Payable i35.1M41.5M36.1M35.1M33.0M
Short-term Debt i21.4M30.1M23.8M18.3M14.2M
Current Portion of Long-term Debt-----
Other Current Liabilities--268.0K2.1M15.0M
Total Current Liabilities i82.1M90.2M75.6M74.9M77.8M
Non-Current Liabilities
Long-term Debt i37.1M23.4M37.4M49.1M42.8M
Deferred Tax Liabilities i2.4M2.6M2.8M3.1M3.3M
Other Non-Current Liabilities-----
Total Non-Current Liabilities i48.8M36.1M51.0M61.5M54.9M
Total Liabilities i130.9M126.3M126.6M136.5M132.7M
Equity
Common Stock i40.4M39.8M39.2M38.7M38.4M
Retained Earnings i10.4M9.4M8.1M5.1M5.7M
Treasury Stock i2.9M2.8M2.8M2.4M1.7M
Other Equity-----
Total Shareholders Equity i214.0M204.3M194.6M188.5M184.5M
Key Metrics
Total Debt i58.5M53.5M61.2M67.4M57.0M
Working Capital i67.6M42.4M36.7M33.9M22.9M

Balance Sheet Composition

Laboratorio Reig Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i11.8M10.5M8.8M5.8M6.4M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-3.3M-18.4M-4.1M-8.9M-4.4M
Operating Cash Flow i7.6M-8.9M-4.4M-6.2M-490.0K
Investing Activities
Capital Expenditures i-20.3M-12.5M-10.8M-19.1M-11.8M
Acquisitions i-6.6M0-2.0M-15.0M-15.0M
Investment Purchases i-5.0M-336.0K-184.0K-282.0K-449.0K
Investment Sales i391.0K226.0K707.0K234.0K186.0K
Investing Cash Flow i-31.4M-12.6M-12.3M-34.2M-27.1M
Financing Activities
Share Repurchases i-3.0K-20.0K-363.0K-753.0K-628.0K
Dividends Paid i-25.0K-41.0K-53.0K-55.0K-88.0K
Debt Issuance i32.9M10.2M13.8M22.9M19.4M
Debt Repayment i-28.4M-18.0M-16.8M-15.2M-11.7M
Financing Cash Flow i5.6M-7.2M-2.0M13.7M9.6M
Free Cash Flow i10.6M6.3M4.7M-5.3M6.6M
Net Change in Cash i-18.3M-28.6M-18.7M-26.7M-18.0M

Cash Flow Trend

Laboratorio Reig Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 35.25
Forward P/E 13.43
Price to Book 1.06
Price to Sales 0.68
PEG Ratio 13.43

Profitability Ratios

Profit Margin 1.89%
Operating Margin -2.47%
Return on Equity 3.03%
Return on Assets 1.49%

Financial Health

Current Ratio 1.71
Debt to Equity 30.99
Beta 0.74

Per Share Data

EPS (TTM) €0.08
Book Value per Share €2.66
Revenue per Share €4.19

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
rjf229.5M35.251.063.03%1.89%30.99
Laboratorios 3.0B23.385.5025.01%17.66%22.50
Almirall S.A 2.4B112.201.651.45%2.02%26.47
Faes Farma S.A 1.3B12.401.8014.83%19.37%11.48
Labiana Health S.A 28.9M104.006.266.92%0.38%1,378.08
Grifols, S.A 7.4B27.301.584.99%4.00%126.87

Financial data is updated regularly. All figures are in the company's reporting currency.